2021
DOI: 10.1016/j.bjoms.2021.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Systematic review and meta-analysis of tracheostomy outcomes in COVID-19 patients

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
36
2
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(52 citation statements)
references
References 75 publications
(379 reference statements)
3
36
2
2
Order By: Relevance
“…This is most likely attributable to the addition of several studies after March 4, 2021. Another meta-analysis has also failed to show that ET improves the rate of overall mortality, but this meta-analysis was limited due to the small number of patients investigated [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…This is most likely attributable to the addition of several studies after March 4, 2021. Another meta-analysis has also failed to show that ET improves the rate of overall mortality, but this meta-analysis was limited due to the small number of patients investigated [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Johansson et al 34 Intravenous prostacyclin failed to show benefit in mortality, ventilator-free days, need for RRT or vasopressor requirement. Ferro et al 35 Early tracheostomy did not confer mortality benefit nor did it decrease the time to ECMO decannulation. Staibano et al 37 Tracheostomy decreased mortality in COVID-19 patients, and early tracheostomy resulted in shorter ICU duration of stay.…”
Section: Covid-19mentioning
confidence: 95%
“…Two meta-analyses from the past year evaluated for similar findings in the COVID-19 population. 35,36…”
Section: Covid-19mentioning
confidence: 99%
See 1 more Smart Citation
“…Tracheostomy is considered an effective alternative to invasive MV via tracheal tube since it helps to reduce dead-space ventilation and decreases airway resistance and the risk of aspiration, as well as the need for sedation, facilitating weaning from a ventilator [ 18 ]. During the COVID-19 pandemic, there was incomplete evidence that early tracheostomy is preferable to late tracheostomy, and there is no compelling evidence that percutaneous is preferable to surgical (open) [ 5 , 19 , 20 , 21 ]. Consequently, the appropriate MV strategy for COVID-19 respiratory failure is still disputed.…”
Section: Introductionmentioning
confidence: 99%